|
Brand name
|
Active ingredient
|
Therapeutic class
|
Packaging
|
Reimbursement class
|
MA number
|
|
ALIFLUS 25/250
|
salmeterol xinafoate 50 mcg + fluticasone propionate 250 mcg/dose
|
Antiasthmatic and COPD
|
1 dispenser - 120 doses
|
A
|
034463125
|
|
ALIFLUS 25/125
|
salmeterol xinafoate 50 mcg + fluticasone propionate 125 mcg/dose
|
Antiasthmatic and COPD
|
1 dispenser - 120 doses
|
A
|
034463113
|
|
ALIFLUS 25/50
|
salmeterol xinafoate 50 mcg + fluticasone propionate 50 mcg/dose
|
Antiasthmatic and COPD
|
1 dispenser - 120 doses
|
A
|
034463101
|
|
ALIFLUS DISKUS 50/500
|
salmeterol xinafoate 50 mcg + fluticasone propionate 500 mcg/dose
|
Antiasthmatic and COPD
|
1 dispenser - 60 doses
|
A
|
034463063
|
|
ALIFLUS DISKUS 50/250
|
salmeterol xinafoate 50 mcg + fluticasone propionate 250 mcg/dose
|
Antiasthmatic and COPD
|
1 dispenser - 60 doses
|
A
|
034463051
|
|
ALIFLUS DISKUS 50/100
|
salmeterol xinafoate 50 mcg + fluticasone propionate 100 mcg/dose
|
Antiasthmatic and COPD
|
1 dispenser - 60 doses
|
A
|
034463048
|
|
ELEBRATO 92/55/22 mcg Dry Powder Inhalers, in single-dose container
|
Fluticasone Furoate 92mcg+ Umeclidinium Bromure 55mcg + Vilanterol Trifenatate 22mcg/dose
|
Treatment of COPD
|
1 inhaler of 30 doses (One inhalation once daily)
|
A-PT
|
045789029
|
| LAVENTAIR ELLIPTA 55/22 |
Umeclidinium 55mcg + Vilanterol 22mcg/dose |
Treatment of COPD |
1 inhaler of 30 doses (One inhalation once daily) |
A - PT |
EU/1/14/899/002 |
| REVINTY ELLIPTA 92/22 |
Fluticasone Furoate 92mcg + Vilanterol 22mcg/dose |
Treatment of Asthma and COPD |
1 inhaler of 30 doses (One inhalation once daily) |
A |
043446020/E |
| REVINTY ELLIPTA 184/22 |
Fluticasone Furoate 184mcg + Vilanterol 22mcg/dose |
Treatment of Asthma |
1 inhaler of 30 doses (One inhalation once daily) |
A |
043446057/E |
|
Rolufta ELLIPTA 55
|
Umeclidinium 55 mcg
|
Treatment of COPD
|
1 inhaler of 30 doses (one inhalation once daily)
|
A |
045321027/E
|